Referências
Principais artigos
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-467.Texto completo Resumo
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.Texto completo Resumo
Artigos de referência
1. Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016 Apr 21;374(16):1533-42.Texto completo Resumo
2. Adams HP Jr, Bendixen BH, Kappelle LJ, et al; TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial (TOAST - Trial of Org 10172 in Acute Stroke Treatment). Stroke. 1993 Jan;24(1):35-41.Texto completo Resumo
3. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007 Nov;38(11):2979-84.Texto completo Resumo
4. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 Jun 22;337(8756):1521-6. Resumo
5. Amarenco P, Bogousslavsky J, Caplan LR, et al. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27(5):502-8.Texto completo Resumo
6. Gao S, Wang YJ, Xu AD, et al. Chinese ischemic stroke subclassification. Front Neurol. 2011;2:6.Texto completo Resumo
7. Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004 Mar;35(3):664-70.Texto completo Resumo
8. Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke. 2024 Mar;55(3):e77-90.Texto completo Resumo
9. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021 Oct;20(10):795-820.Texto completo Resumo
10. Seth SM, Aaron WA, Zaid IA, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024 Jan 24;149:e347-913.Texto completo
11. Tsao CW, Aday AW, Almarzooq ZI, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-621.Texto completo Resumo
12. Gardener H, Sacco RL, Rundek T, et al. Race and ethnic disparities in stroke incidence in the Northern Manhattan Study. Stroke. 2020 Apr;51(4):1064-9.Texto completo Resumo
13. Howard G, Moy CS, Howard VJ, et al. Where to focus efforts to reduce the Black-White disparity in stroke mortality: incidence versus case fatality? Stroke. 2016 Jul;47(7):1893-8.Texto completo Resumo
14. Xiuyun W, Qian W, Minjun X, et al. Education and stroke: evidence from epidemiology and Mendelian randomization study. Sci Rep. 2020 Dec 3;10(1):21208.Texto completo Resumo
15. Cruz-Flores S, Rabinstein A, Biller J, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Jul;42(7):2091-116.Texto completo Resumo
16. Khan M, Arauz A, Uluduz D, et al. Predictors of mortality and functional outcome in pregnancy and puerperium-related cerebral venous thrombosis. Cerebrovasc Dis. 2023;52(4):393-400.Texto completo Resumo
17. Kashkoush AI, Ma H, Agarwal N, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: a pooled, systematic review. J Clin Neurosci. 2017 May;39:9-15.Texto completo Resumo
18. Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018 Sep;17(9):790-801. Resumo
19. Seminog OO, Scarborough P, Wright FL, et al. Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults. BMJ. 2019 May 22;365:l1778.Texto completo Resumo
20. Lanas F, Seron P. Facing the stroke burden worldwide. Lancet Glob Health. 2021 Mar;9(3):e235-6.Texto completo Resumo
21. Pandian JD, Gall SL, Kate MP, et al. Prevention of stroke: a global perspective. Lancet. 2018 Oct 6;392(10154):1269-78. Resumo
22. Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017 Feb 21;135(8):759-71.Texto completo Resumo
23. Ezejimofor MC, Chen YF, Kandala NB, et al. Stroke survivors in low- and middle-income countries: a meta-analysis of prevalence and secular trends. J Neurol Sci. 2016 May 15;364:68-76.Texto completo Resumo
24. Turan TN, Zaidat OO, Gronseth GS, et al. Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: report of the AAN guideline subcommittee. Neurology. 2022 Mar 22;98(12):486-98.Texto completo Resumo
25. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994 Dec 1;331(22):1474-9.Texto completo Resumo
26. Amarenco P, Cohen A, Hommel M, et al; French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996 May 9;334(19):1216-21.Texto completo Resumo
27. Sacco RL. Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology. 1997 Nov;49(5 suppl 4):S39-44. Resumo
28. Spence JD. Controlling resistant hypertension. Stroke Vasc Neurol. 2018 Jun;3(2):69-75.Texto completo Resumo
29. Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012 Oct 23;79(17):1781-7.Texto completo Resumo
30. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 2;339(1):5-11.Texto completo Resumo
31. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004 Jan;35(1):212-27.Texto completo Resumo
32. Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018 Apr;50(4):524-37. [Erratum in: Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2019 Jul;51(7):1192-3.]Texto completo Resumo
33. Dichgans M, Pulit SL, Rosand J. Stroke genetics: discovery, biology, and clinical applications. Lancet Neurol. 2019 Jun;18(6):587-99. Resumo
34. Barrett KM, Meschia JF. Genetic stroke syndromes. Continuum (Minneap Minn). 2014 Apr;20(2 cerebrovascular disease):399-411.Texto completo Resumo
35. Shahjouei S, Sadighi A, Chaudhary D, et al. A 5-decade analysis of incidence trends of ischemic stroke after transient ischemic attack: a systematic review and meta-analysis. JAMA Neurol. 2021 Jan 1;78(1):77-87.Texto completo Resumo
36. Lioutas VA, Ivan CS, Himali JJ, et al. Incidence of transient ischemic attack and association with long-term risk of stroke. JAMA. 2021 Jan 26;325(4):373-81.Texto completo Resumo
37. Charidimou A, Shams S, Romero JR, et al; International META-MICROBLEEDS Initiative. Clinical significance of cerebral microbleeds on MRI: a comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1). Int J Stroke. 2018 Jul;13(5):454-68.Texto completo Resumo
38. Wolf PA, D'Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988 Feb 19;259(7):1025-9. Resumo
39. Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018 Jan 24;360:j5855.Texto completo Resumo
40. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979 May 11;241(19):2035-8. Resumo
41. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991 Aug;22(8):983-8. Resumo
42. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001 Jan;32(1):280-99.Texto completo Resumo
43. Lüscher TF. Stroke: cardiac causes and their management. Eur Heart J. 2015 Sep 14;36(35):2339-41.Texto completo Resumo
44. Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med. 1986 Oct 2;315(14):860-5. Resumo
45. Barnett HJ, Taylor DW, Haynes RB, et al; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 Aug 15;325(7):445-53.Texto completo Resumo
46. Barnett HJ, Taylor DW, Eliasziw M, et al; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998 Nov 12;339(20):1415-25.Texto completo Resumo
47. Kim JS, Bonovich D. Research on intracranial atherosclerosis from the East and west: why are the results different? J Stroke. 2014 Sep;16(3):105-13.Texto completo Resumo
48. Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989 Apr 6;320(14):904-10. Resumo
49. Baigent C, Blackwell L, Emberson J, et al; Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010 Nov 13;376(9753):1670-81.Texto completo Resumo
50. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532-61.Texto completo Resumo
51. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis. 2008 Feb;196(2):489-96. Resumo
52. Yang Q, Tong X, Schieb L, et al. Vital signs: recent trends in stroke death rates - United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):933-9.Texto completo Resumo
53. Howard VJ. Reasons underlying racial differences in stroke incidence and mortality. Stroke. 2013 Jun;44(6 suppl 1):S126-8.Texto completo Resumo
54. Oshunbade AA, Yimer WK, Valle KA, et al. Cigarette smoking and incident stroke in blacks of the Jackson Heart Study. J Am Heart Assoc. 2020 Jun 16;9(12):e014990.Texto completo Resumo
55. Bazzano LA, Serdula MK, Liu S. Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep. 2003 Nov;5(6):492-9. Resumo
56. He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999 Dec 1;282(21):2027-34.Texto completo Resumo
57. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality: a 12-year prospective population study. N Engl J Med. 1987 Jan 29;316(5):235-40. Resumo
58. Tong TYN, Appleby PN, Key TJ, et al. The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries. Eur Heart J. 2020 Jul 21;41(28):2632-40.Texto completo Resumo
59. Spence JD. Diet for stroke prevention. Stroke Vasc Neurol. 2018 Jun;3(2):44-50.Texto completo Resumo
60. Muto M, Ezaki O. High dietary saturated fat is associated with a low risk of intracerebral hemorrhage and ischemic stroke in Japanese but not in non-Japanese: a review and meta-analysis of prospective cohort studies. J Atheroscler Thromb. 2018 May 1;25(5):375-92.Texto completo Resumo
61. Barker DJ, Lackland DT. Prenatal influences on stroke mortality in England and Wales. Stroke. 2003 Jul;34(7):1598-602.Texto completo Resumo
62. Prior PL, Suskin N. Exercise for stroke prevention. Stroke Vasc Neurol. 2018 Jun;3(2):59-68.Texto completo Resumo
63. Kurth T, Gaziano JM, Rexrode KM, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation. 2005 Apr 19;111(15):1992-8.Texto completo Resumo
64. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002 Dec 9-23;162(22):2557-62.Texto completo Resumo
65. Patra J, Taylor B, Irving H, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types - a systematic review and meta-analysis. BMC Public Health. 2010 May 18;10:258.Texto completo Resumo
66. Millwood IY, Walters RG, Mei XW, et al; China Kadoorie Biobank Collaborative Group. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019 May 4;393(10183):1831-42.Texto completo Resumo
67. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA. 2000 Jul 5;284(1):72-8. Resumo
68. Carlton C, Banks M, Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018 Apr;49(4):e157-9.Texto completo Resumo
69. Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006 May 23;113(20):2425-34.Texto completo Resumo
70. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33.Texto completo Resumo
71. Sacco S, Merki-Feld GS, Ægidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108.Texto completo Resumo
72. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005 Mar 22;64(6):1020-6. Resumo
73. Adelborg K, Szépligeti SK, Holland-Bill L, et al. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018 Jan 31;360:k96.Texto completo Resumo
74. Martinez-Majander N, Artto V, Ylikotila P, et al. Association between migraine and cryptogenic ischemic stroke in young adults. Ann Neurol. 2021 Feb;89(2):242-53.Texto completo Resumo
75. Bassetti CLA, Randerath W, Vignatelli L, et al. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur J Neurol. 2020 Jul;27(7):1117-36.Texto completo Resumo
76. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 Jul 20;144(3):e56-67.Texto completo Resumo
77. Zhou L, Yu K, Yang L, et al. Sleep duration, midday napping, and sleep quality and incident stroke: the Dongfeng-Tongji cohort. Neurology. 2020 Jan 28;94(4):e345-56. Resumo
78. Lappin JM, Darke S, Farrell M. Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1079-91.Texto completo Resumo
79. Spence JD, Bang H, Chambless LE, et al. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke. 2005 Nov;36(11):2404-9.Texto completo Resumo
80. Lonn E, Yusuf S, Arnold MJ, et al; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006 Apr 13;354(15):1567-77.Texto completo Resumo
81. Bønaa KH, Njølstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13;354(15):1578-88.Texto completo Resumo
82. Keene D, Price C, Shun-Shin MJ, et al. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014 Jul 18;349:g4379.Texto completo Resumo
83. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020 Oct;20(5):356-67.Texto completo Resumo
84. Kuo HK, Yen CJ, Chang CH, et al. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005 Jun;4(6):371-80. Resumo
85. Amarenco P, Davis S, Jones EF, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014 May;45(5):1248-57.Texto completo Resumo
86. Di Tullio MR, Russo C, Jin Z, et al. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009 May 5;119(17):2376-82.Texto completo Resumo
87. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc. 1999 Sep;74(9):862-9. Resumo
88. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984 Jan;59(1):17-20.Texto completo Resumo
89. Spence JD. Cardioembolic stroke: everything has changed. Stroke Vasc Neurol. 2018 Jun;3(2):76-83.Texto completo Resumo
90. Kim H, Kim J, Kim S, et al. Cardiovascular effects of long-term exposure to air pollution: a population-based study with 900 845 person-years of follow-up. J Am Heart Assoc. 2017 Nov 8;6(11):e007170.Texto completo Resumo
91. Willett J, Achenbach S, Pinto FJ, et al. The tobacco endgame: eradicating a worsening epidemic: a joint opinion from the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. J Am Coll Cardiol. 2021 Jul 6;78(1):77-81.Texto completo Resumo
92. Simonetto M, Wechsler PM, Merkler AE. Stroke treatment in the era of COVID-19: a review. Curr Treat Options Neurol. 2022;24(4):155-71.Texto completo Resumo
93. Nguyen TN, Qureshi MM, Klein P, et al. Global impact of the COVID-19 pandemic on cerebral venous thrombosis and mortality. J Stroke. 2022 May;24(2):256-65.Texto completo Resumo
94. Furie KL, Cushman M, Elkind MSV, et al. Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke. 2021 Jul;52(7):2478-82.Texto completo Resumo
95. Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2124-30.Texto completo Resumo
96. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2092-101.Texto completo Resumo
97. Fan BE, Ling RR, Ramanathan K, et al. COVID-19 mRNA vaccine-associated cerebral venous thrombosis: rare adverse event or coincidence? Am J Hematol. 2023 Jan;98(1):E4-7.Texto completo Resumo
98. Thompson AM, Hu T, Eshelbrenner CL, et al. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011 Mar 2;305(9):913-22.Texto completo Resumo
99. Rutten-Jacobs LC, Larsson SC, Malik R, et al. Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants. BMJ. 2018 Oct 24;363:k4168.Texto completo Resumo
100. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006186.Texto completo Resumo
101. Culebras A, Messé SR, Chaturvedi S, et al. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Feb 25;82(8):716-24.Texto completo Resumo
102. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-467.Texto completo Resumo
103. Whitlock RP, Belley-Cote EP, Paparella D, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021 Jun 3;384(22):2081-91.Texto completo Resumo
104. De Caterina R, Salvatore T, Marchioli R. Cholesterol-lowering interventions and stroke: insights from IMPROVE-IT. Atherosclerosis. 2016 May;248:216-8. Resumo
105. Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015 Jun 18;372(25):2387-97.Texto completo Resumo
106. Schmidt AF, Carter JL, Pearce LS, et al. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020 Oct 20;10:CD011748.Texto completo Resumo
107. Sabatine MS, Giugliano RP, Wiviott SD, et al; Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16;372(16):1500-9.Texto completo Resumo
108. Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017 May 4;376(18):1713-22.Texto completo Resumo
109. Robinson JG, Farnier M, Krempf M, et al; ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16;372(16):1489-99.Texto completo Resumo
110. Schwartz GG, Steg PG, Szarek M, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018 Nov 29;379(22):2097-107.Texto completo Resumo
111. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Sep 10;74(10):e177-232.Texto completo Resumo
112. US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA. 2022 Apr 26;327(16):1577-84.Texto completo Resumo
113. Gaziano JM, Brotons C, Coppolecchia R, et al; ARRIVE Executive Committee. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018 Sep 22;392(10152):1036-46. Resumo
114. McNeil JJ, Wolfe R, Woods RL, et al; ASPREE Investigator Group. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018 Oct 18;379(16):1509-18.Texto completo Resumo
115. Bowman L, Mafham M, Wallendszus K, et al; ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med. 2018 Oct 18;379(16):1529-39.Texto completo Resumo
116. Sharma M, Hart RG, Connolly SJ, et al. Stroke outcomes in the COMPASS Trial. Circulation. 2019 Feb 26;139(9):1134-45.Texto completo Resumo
117. Alberts MJ, Latchaw RE, Jagoda A, et al. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke. 2011 Sep;42(9):2651-65.Texto completo Resumo
118. Tao WD, Liu M, Fisher M, et al. Posterior versus anterior circulation infarction: how different are the neurological deficits? Stroke. 2012 Aug;43(8):2060-5.Texto completo Resumo
119. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.Texto completo Resumo
120. American College of Radiology. ACR appropriateness criteria: cerebrovascular diseases-stroke and stroke-related conditions. 2023 [internet publication].Texto completo
121. Schwamm LH, Wu O, Song SS, et al; MR WITNESS Investigators. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results. Ann Neurol. 2018 May;83(5):980-93.Texto completo Resumo
122. Campbell BC, Ma H, Ringleb PA, et al; EXTEND, ECASS-4, and EPITHET Investigators. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019 Jul 13;394(10193):139-47. Resumo
123. Campbell BCV, Ma H, Parsons MW, et al. Association of reperfusion after thrombolysis with clinical outcome across the 4.5- to 9-hours and wake-up stroke time window: a meta-analysis of the EXTEND and EPITHET randomized clinical trials. JAMA Neurol. 2021 Feb 1;78(2):236-40. Resumo
124. Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014 Jun 26;370(26):2478-86.Texto completo Resumo
125. Gladstone DJ, Spring M, Dorian P, et al; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014 Jun 26;370(26):2467-77.Texto completo Resumo
126. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017 Feb 3;120(3):472-95.Texto completo Resumo
127. Kamel H, Healey JS. Cardioembolic stroke. Circ Res. 2017 Feb 3;120(3):514-26.Texto completo Resumo
128. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol. 2006 Sep;60(3):301-13.Texto completo Resumo
129. Kiyohara T, Kamouchi M, Kumai Y, et al. ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack. Stroke. 2014 Feb;45(2):418-25.Texto completo Resumo
130. Zhao M, Wang S, Zhang D, et al. Comparison of stroke prediction accuracy of ABCD2 and ABCD3-I in patients with transient ischemic attack: a meta-analysis. J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2387-95. Resumo
131. Mayer L, Ferrari J, Krebs S, et al; Austrian Stroke Unit Collaborators. ABCD3-I score and the risk of early or 3-month stroke recurrence in tissue- and time-based definitions of TIA and minor stroke. J Neurol. 2018 Mar;265(3):530-4.Texto completo Resumo
132. National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. April 2022 [internet publication].Texto completo
133. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007 Dec;6(12):1063-72. Resumo
134. Higgins P, MacFarlane PW, Dawson J, et al. Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke. 2013 Sep;44(9):2525-31.Texto completo Resumo
135. Hill MD, Demchuk AM, Tomsick TA, et al. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol. 2006 Sep;27(8):1612-6.Texto completo Resumo
136. Caplan L. Caplan's stroke: a clinical approach. 4th ed. Philadelphia, PA: Saunders; 2009.
137. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007 Jan 27;369(9558):293-8.Texto completo Resumo
138. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003 Sep;34(9):2208-14.Texto completo Resumo
139. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001 Nov 13;57(9):1603-10. Resumo
140. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999 Jan;30(1):34-9.Texto completo Resumo
141. Amarenco P. Transient Ischemic Attack. N Engl J Med. 2020 May 14;382(20):1933-1941.Texto completo Resumo
142. Roch JA, Nighoghossian N, Hermier M, et al. Transient neurologic symptoms related to cerebral amyloid angiopathy: usefulness of T2*-weighted imaging. Cerebrovasc Dis. 2005;20(5):412-4. Resumo
143. Wardlaw JM, Murray V, Berge E, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jul 29;(7):CD000213.Texto completo Resumo
144. Man S, Xian Y, Holmes DN, et al. Association between thrombolytic door-to-needle time and 1-year mortality and readmission in patients with acute ischemic stroke. JAMA. 2020 Jun 2;323(21):2170-84.Texto completo Resumo
145. Hacke W, Kaste M, Bluhmki E, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.Texto completo Resumo
146. Whiteley WN, Emberson J, Lees KR, et al. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol. 2016 Aug;15(9):925-33. Resumo
147. Alamowitch S, Turc G, Palaiodimou L, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J. 2023 Mar;8(1):8-54.Texto completo Resumo
148. Kheiri B, Osman M, Abdalla A, et al. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2018 Nov;46(4):440-50. Resumo
149. Burgos AM, Saver JL. Evidence that tenecteplase Is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials. Stroke. 2019 Aug;50(8):2156-62.Texto completo Resumo
150. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Acute Ischemic Stroke, Lo BM, Carpenter CR, et al. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with acute ischemic stroke. Ann Emerg Med. 2023 Aug;82(2):e17-e64.Texto completo Resumo
151. Sattin JA, Chiong W, Bonnie RJ, et al. Consent issues in the management of acute ischemic stroke: AAN position statement. Neurology. 2022 Jan 11;98(2):73-9.Texto completo Resumo
152. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004 Jul;61(7):1066-70.Texto completo Resumo
153. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1581-7.Texto completo Resumo
154. Ganesh A, Fraser JF, Gordon Perue GL, et al. Endovascular treatment and thrombolysis for acute ischemic stroke in patients with premorbid disability or dementia: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2022 May;53(5):e204-e217.Texto completo Resumo
155. Ma H, Campbell BC, Parsons MW, et al; EXTEND Investigators. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019 May 9;380(19):1795-803.Texto completo Resumo
156. Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021 Mar;6(1):I-LXII.Texto completo Resumo
157. Bluhmki E, Danays T, Biegert G, et al. Alteplase for acute ischemic stroke in patients aged >80 years: pooled analyses of individual patient data. Stroke. 2020 Aug;51(8):2322-31.Texto completo Resumo
158. Hacke W, Lyden P, Emberson J, et al. Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: individual-patient-data meta-analysis of randomized trials. Int J Stroke. 2018 Feb;13(2):175-s89.Texto completo Resumo
159. Zinkstok SM, Roos YB; ARTIS investigators. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet. 2012 Aug 25;380(9843):731-7. Resumo
160. Wang Y, Johnston SC, Bath PM, et al. Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack. BMJ. 2019 Feb 28;364:l895.Texto completo Resumo
161. Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007 Nov;6(11):961-9. Resumo
162. Hao Q, Tampi M, O'Donnell M, et al. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ. 2018 Dec 18;363:k5108.Texto completo Resumo
163. Rahman H, Khan SU, Nasir F, et al. Optimal duration of aspirin plus clopidogrel after ischemic stroke or transient ischemic attack. Stroke. 2019 Apr;50(4):947-53.Texto completo Resumo
164. Johnston SC, Amarenco P, Denison H, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020 Jul 16;383(3):207-17.Texto completo Resumo
165. Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021 Dec 30;385(27):2520-30.Texto completo Resumo
166. Sacks D, Baxter B, Campbell BCV, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke: from the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO). J Vasc Interv Radiol. 2018 Apr;29(4):441-53.Texto completo Resumo
167. Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic stroke: endorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J. 2019 Mar;4(1):6-12.Texto completo Resumo
168. Campbell BC, Donnan GA, Mitchell PJ, et al. Endovascular thrombectomy for stroke: current best practice and future goals. Stroke Vasc Neurol. 2016 Feb 16;1(1):16-22.Texto completo Resumo
169. Rodrigues FB, Neves JB, Caldeira D, et al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016 Apr 18;353:i1754.Texto completo Resumo
170. Mueller-Kronast NH, Zaidat OO, Froehler MT, et al; STRATIS Investigators. Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS Registry. Stroke. 2017 Oct;48(10):2760-8.Texto completo Resumo
171. Vidale S, Agostoni E. Endovascular treatment of ischemic stroke: an updated meta-analysis of efficacy and safety. Vasc Endovascular Surg. 2017 May;51(4):215-9. Resumo
172. Roaldsen MB, Jusufovic M, Berge E, et al. Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke. Cochrane Database Syst Rev. 2021 Jun 14;6:CD007574.Texto completo Resumo
173. Griessenauer CJ, Medin C, Maingard J, et al. Endovascular mechanical thrombectomy in large-vessel occlusion ischemic stroke presenting with low National Institutes of Health Stroke Scale: systematic review and meta-analysis. World Neurosurg. 2018 Feb;110:263-9. Resumo
174. Katsanos AH, Turc G, Psychogios M, et al. Utility of intravenous alteplase prior to endovascular stroke treatment: a systematic review and meta-analysis of RCTs. Neurology. 2021 Aug 24;97(8):e777-e784. Resumo
175. LeCouffe NE, Kappelhof M, Treurniet KM, et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med. 2021 Nov 11;385(20):1833-44.Texto completo Resumo
176. Balami JS, White PM, McMeekin PJ, et al. Complications of endovascular treatment for acute ischemic stroke: prevention and management. Int J Stroke. 2018 Jun;13(4):348-61. Resumo
177. Campbell BC, van Zwam WH, Goyal M, et al; HERMES collaborators. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018 Jan;17(1):47-53. Resumo
178. Nogueira RG, Jadhav AP, Haussen DC, et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018 Jan 4;378(1):11-21.Texto completo Resumo
179. Albers GW, Marks MP, Kemp S, et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018 Feb 22;378(8):708-18.Texto completo Resumo
180. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999 Dec 1;282(21):2003-11.Texto completo Resumo
181. Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015 Mar 12;(3):CD000024.Texto completo Resumo
182. Yi X, Lin J, Wang C, et al. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome. J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1537-44. Resumo
183. Wang QS, Chen C, Chen XY, et al. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study. Stroke. 2012 Feb;43(2):346-9.Texto completo Resumo
184. Lip GY, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018 Nov;154(5):1121-201.Texto completo Resumo
185. Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012 Aug 14;126(7):860-5.Texto completo Resumo
186. Feldman W. Treatment of occult bacteremia. Pediatrics. 1984 Dec;74(6):1131-3. Resumo
187. Rerkasem A, Orrapin S, Howard DP, et al. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2020 Sep 12;9:CD001081.Texto completo Resumo
188. Brott TG, Hobson RW 2nd, Howard G, et al; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1;363(1):11-23.Texto completo Resumo
189. Brott TG, Howard G, Roubin GS, et al; CREST Investigators. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016 Mar 17;374(11):1021-31.Texto completo Resumo
190. Messé SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline subcommittee of the American Academy of Neurology. Neurology. 2020 May 19;94(20):876-85.Texto completo Resumo
191. Kuijpers T, Spencer FA, Siemieniuk RA, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ. 2018 Jul 25;362:k2515.Texto completo Resumo
192. Ahmed N, Steiner T, Caso V, et al; ESO-KSU session participants. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13-15 November 2016. Eur Stroke J. 2017 Jun;2(2):95-102.Texto completo
193. Ahmad Y, Howard JP, Arnold A, et al. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. 2018 May 7;39(18):1638-49.Texto completo Resumo
194. Lattanzi S, Brigo F, Cagnetti C, et al. Patent foramen ovale and cryptogenic stroke or transient ischemic attack: to close or not to close? A systematic review and meta-analysis. Cerebrovasc Dis. 2018;45(5-6):193-203.Texto completo Resumo
195. Ntaios G, Papavasileiou V, Sagris D, et al. Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke. 2018 Feb;49(2):412-8.Texto completo Resumo
196. Vidale S, Russo F, Campana C, et al. Patent foramen ovale closure versus medical therapy in cryptogenic strokes and transient ischemic attacks: a meta-analysis of randomized trials. Angiology. 2019 Apr;70(4):325-31. Resumo
197. Mir H, Siemieniuk RA, Ge L, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence. BMJ Open. 2018 Jul 25;8(7):e023761.Texto completo Resumo
198. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017 Oct;24(10):1203-13.Texto completo Resumo
199. Zuurbier SM, Arnold M, Middeldorp S, et al. Risk of cerebral venous thrombosis in obese women. JAMA Neurol. 2016 May 1;73(5):579-84.Texto completo Resumo
200. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020 Jun;5(2):152-8.Texto completo Resumo
201. Ferro JM, Coutinho JM, Dentali F, et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019 Dec 1;76(12):1457-65.Texto completo Resumo
202. Field TS, Dizonno V, Almekhlafi MA, et al. Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis. Stroke. 2023 Nov;54(11):2724-36.Texto completo Resumo
203. Yaghi S, Shu L, Bakradze E, et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022 Mar;53(3):728-38.Texto completo Resumo
204. Yaghi S, Saldanha IJ, Misquith C, et al. Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke. 2022 Oct;53(10):3014-24.Texto completo Resumo
205. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):e1082-143.Texto completo Resumo
206. Amarenco P, Kim JS, Labreuche J, et al. A Comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020 Jan 2;382(1):9.Texto completo Resumo
207. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018 Apr 28;391(10131):1693-705. Resumo
208. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018 Oct 24;363:k4169.Texto completo Resumo
209. Rønning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999 Oct;30(10):2033-7.Texto completo Resumo
210. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: adult advanced life support. Resuscitation. 2021 Apr;161:115-51.Texto completo Resumo
211. Colquhoun MC, Handley AJ, Evans TR, eds. ABC of resuscitation. 5th ed. Wiley-Blackwell; 2004.
212. Chrimes N, Higgs A, Hagberg CA, et al. Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societies. Anaesthesia. 2022 Aug 17 [Epub ahead of print].Texto completo Resumo
213. Ahmed N, Näsman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000 Jun;31(6):1250-5.Texto completo Resumo
214. Anderson CS, Huang Y, Lindley RI, et al; ENCHANTED Investigators and Coordinators. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019 Mar 2;393(10174):877-88. Resumo
215. Sandset EC, Anderson CS, Bath PM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J. 2021 Jun;6(2):XLVIII-LXXXIX.Texto completo Resumo
216. Johnston KC, Bruno A, Pauls Q, et al; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019 Jul 23;322(4):326-35.Texto completo Resumo
217. Fuentes B, Ntaios G, Putaala J, et al. European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. Eur Stroke J. 2018 Mar;3(1):5-21.Texto completo Resumo
218. Saxena M, Young P, Pilcher D, et al. Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med. 2015 May;41(5):823-32.Texto completo Resumo
219. Krieger DW, Yenari MA. Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke. 2004 Jun;35(6):1482-9.Texto completo Resumo
220. Den Hertog HM, van der Worp HB, Tseng MC, et al. Cooling therapy for acute stroke. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001247.Texto completo Resumo
221. Ntaios G, Dziedzic T, Michel P, et al. European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke. Int J Stroke. 2015 Aug;10(6):941-9.Texto completo Resumo
222. Langhorne P, Ramachandra S, Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database Syst Rev. 2020 Apr 23;(4):CD000197.Texto completo Resumo
223. Adeoye O, Nyström KV, Yavagal DR, et al. Recommendations for the establishment of stroke systems of care: a 2019 update. Stroke. 2019 Jul;50(7):e187-210.Texto completo Resumo
224. National Institute for Health and Care Excellence. Stroke rehabilitation in adults. Jun 2013 [internet publication].Texto completo
225. Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005 Dec;36(12):2756-63.Texto completo Resumo
226. Mann G, Hankey GJ, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke. 1999 Apr;30(4):744-8.Texto completo Resumo
227. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997 Apr;72(4):297-300. Resumo
228. Dennis M, Caso V, Kappelle LJ, et al; European Stroke Organisation. European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J. 2016 Mar;1(1):6-19.Texto completo Resumo
229. Dennis M, Sandercock P, Reid J, et al; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013 Aug 10;382(9891):516-24.Texto completo Resumo
230. AVERT Trial Collaboration group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015 Jul 4;386(9988):46-55.Texto completo Resumo
231. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-169.Texto completo Resumo
232. Pedersen PM, Vinter K, Olsen TS. Aphasia after stroke: type, severity and prognosis. The Copenhagen aphasia study. Cerebrovasc Dis. 2004;17(1):35-43.Texto completo Resumo
233. Brady MC, Kelly H, Godwin J, et al. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev. 2016 Jun 1;(6):CD000425.Texto completo Resumo
234. Barclay RE, Stevenson TJ, Poluha W, et al. Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke. Cochrane Database Syst Rev. 2020 May 25;5:CD005950.Texto completo Resumo
235. Laver KE, Lange B, George S, et al. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2017 Nov 20;(11):CD008349.Texto completo Resumo
236. Tomida K, Sonoda S, Hirano S, et al. Randomized controlled trial of gait training using Gait Exercise Assist Robot (GEAR) in stroke patients with hemiplegia. J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2421-8. Resumo
237. Rothwell PM, Algra A, Chen Z, et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet. 2016 Jul 23;388(10042):365-75.Texto completo Resumo
238. Thomalla G, Simonsen CZ, Boutitie F, et al; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018 Aug 16;379(7):611-22.Texto completo Resumo
239. Thomalla G, Boutitie F, Ma H, et al. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. Lancet. 2020 Nov 14;396(10262):1574-84. Resumo
240. Cheng JW, Zhang XJ, Cheng LS, et al. Low-dose tissue plasminogen activator in acute ischemic stroke: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2018 Feb;27(2):381-90. Resumo
241. Wang X, You S, Sato S, et al. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review. Stroke Vasc Neurol. 2018 Mar;3(1):28-33.Texto completo Resumo
242. Wang Y, Liu M, Pu C. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack. Int J Stroke. 2017 Apr;12(3):302-20. Resumo
243. Xu J, Wang A, Meng X, et al. Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase III, randomized, double-blind, comparative trial. Stroke. 2021 Mar;52(3):772-80.Texto completo Resumo
244. Alexander-Curtis M, Pauls R, Chao J, et al. Human tissue kallikrein in the treatment of acute ischemic stroke. Ther Adv Neurol Disord. 2019;12:1756286418821918.Texto completo Resumo
245. Bundy DT, Souders L, Baranyai K, et al. Contralesional brain-computer interface control of a powered exoskeleton for motor recovery in chronic stroke survivors. Stroke. 2017 Jul;48(7):1908-15.Texto completo Resumo
246. Kamal AK, Naqvi I, Husain MR, et al. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008076.Texto completo Resumo
247. Huang HP, Lin WH, Chen SG, et al. Comparative efficacy and safety of nine anti-platelet therapies for patients with ischemic stroke or transient ischemic attack: a mixed treatment comparisons. Mol Neurobiol. 2017 Mar;54(2):1456-66. Resumo
248. Toyoda K, Uchiyama S, Yamaguchi T, et al; CSPS.com Trial Investigators. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2019 Jun;18(6):539-48. Resumo
249. Cooray C, Mazya M, Bottai M, et al. External validation of the ASTRAL and DRAGON scores for prediction of functional outcome in stroke. Stroke. 2016 Jun;47(6):1493-9.Texto completo Resumo
250. Hiltunen S, Putaala J, Haapaniemi E, et al. Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients. J Neurol. 2016 Mar;263(3):477-84.Texto completo Resumo
251. Koopman K, Uyttenboogaart M, Vroomen PC, et al. Long-term sequelae after cerebral venous thrombosis in functionally independent patients. J Stroke Cerebrovasc Dis. 2009 May-Jun;18(3):198-202.Texto completo Resumo
252. Preter M, Tzourio C, Ameri A, et al. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke. 1996 Feb;27(2):243-6.Texto completo Resumo
253. Klein P, Shu L, Nguyen TN, et al. Outcome prediction in cerebral venous thrombosis: the IN-REvASC score. J Stroke. 2022 Sep;24(3):404-16.Texto completo Resumo
254. Ferrarello F, Baccini M, Rinaldi LA, et al. Efficacy of physiotherapy interventions late after stroke: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):136-43. Resumo
255. Starkstein SE, Mizrahi R, Power BD. Antidepressant therapy in post-stroke depression. Expert Opin Pharmacother. 2008 Jun;9(8):1291-8. Resumo
256. Wang JZ, Vyas MV, Saposnik G, et al. Incidence and management of seizures after ischemic stroke: systematic review and meta-analysis. Neurology. 2017 Sep 19;89(12):1220-8. Resumo
257. Jensen MB, St Louis EK. Management of acute cerebellar stroke. Arch Neurol. 2005 Apr;62(4):537-44.Texto completo Resumo
258. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007 Mar;6(3):215-22. Resumo
259. Alawneh JA, Hutchinson PA, Warburton E. Stroke management: decompressive hemicraniectomy. Systematic review 0201. BMJ Clin Evid. 2015;2015:0201.Texto completo
260. Hinkle JL, Becker KJ, Kim JS, et al. Poststroke fatigue: emerging evidence and approaches to management: a scientific statement for healthcare professionals from the American Heart Association. Stroke. 2017 Jul;48(7):e159-e170.Texto completo Resumo
261. Becker K, Kohen R, Lee R, et al. Poststroke fatigue: hints to a biological mechanism. J Stroke Cerebrovasc Dis. 2015 Mar;24(3):618-21. Resumo
262. Wu S, Kutlubaev MA, Chun HY, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev. 2015 Jul 2;(7):CD007030.Texto completo Resumo
263. Choi-Kwon S, Kim JS. Poststroke fatigue: an emerging, critical issue in stroke medicine. Int J Stroke. 2011 Aug;6(4):328-36. Resumo
264. Hickey A, Merriman NA, Bruen C, et al. Psychological interventions for managing cognitive impairment after stroke. Cochrane Database Syst Rev. 2019 Aug 22;2019(8):CD013406.Texto completo
265. Mellon L, Brewer L, Hall P, et al. Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study. BMC Neurol. 2015 Mar 12;15:31.Texto completo Resumo
266. Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019 Jun;4(2):160-71.Texto completo Resumo
267. Jokinen H, Melkas S, Ylikoski R, et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015 Sep;22(9):1288-94. Resumo
268. Arba F, Quinn T, Hankey GJ, et al. Determinants of post-stroke cognitive impairment: analysis from VISTA. Acta Neurol Scand. 2017 Jun;135(6):603-7. Resumo
269. Quinn TJ, Richard E, Teuschl Y, et al. European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. Eur J Neurol. 2021 Dec;28(12):3883-3920.Texto completo Resumo
270. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006 Mar;151(3):713-9. Resumo
271. Zonneveld TP, Richard E, Vergouwen MD, et al. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018 Jul 19;(7):CD007858.Texto completo Resumo
272. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269-324.Texto completo Resumo
273. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019 Jan 3;380(1):11-22.Texto completo Resumo
274. Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis. J Clin Neurosci. 2019 Feb;60:24-30. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal